image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 132.02
-1.56 %
$ 13.1 B
Market Cap
44.75
P/E
Price Target Average
16.30%
Revenue Forecast Estimate
14.74%
EBIT Estimate
12.07%
Net Income Estimate
36.07%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Neurocrine Biosciences, Inc.
image
Wall Street analysts predict an average 1-year price target for NBIX of $154 , with forecasts ranging from a low of $121 to a high of $192 .
NBIX Lowest Price Target Wall Street Target
121 USD -8.35%
NBIX Average Price Target Wall Street Target
154 USD 16.30%
NBIX Highest Price Target Wall Street Target
192 USD 45.43%
Price
Max Price Target
Min Price Target
Average Price Target
2002001801801601601401401201201001008080Jun '24Jun '24Aug '24Aug '24Oct '24Oct '24Dec '24Dec '24Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Aug '25Aug '25Oct '25Oct '25Dec '25Dec '25Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart NBIX

image
$4.5b$4.5b$4.0b$4.0b$3.5b$3.5b$3.0b$3.0b$2.5b$2.5b$2.0b$2.0b$1.5b$1.5b$1.0b$1.0b$500.0m$500.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart NBIX

image
$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart NBIX

image
$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029